IDEXX Laboratories, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 22.76%

IDEXX Laboratories, Inc. Net Income Margin is 22.76% for the Trailing 12 Months (TTM) ending March 31, 2025, a -2.16% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • IDEXX Laboratories, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 23.26%, a 14.16% change year over year.
  • IDEXX Laboratories, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 20.38%, a -9.17% change year over year.
  • IDEXX Laboratories, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 22.43%, a -4.90% change year over year.
  • IDEXX Laboratories, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 23.59%, a 32.68% change year over year.
Key Data
Date Net Income Margin EBT Margin Operating Income Margin Gross Profit Margin